Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Red bahman is a traditional medicinal root derived from the plant *Salvia haematodes* L., primarily utilized in Iranian Traditional Medicine (ITM) for its purported aphrodisiac, tonic, and spermatogenic properties. It is traditionally prescribed to treat male sexual dysfunction and infertility. Clinical research, such as studies conducted at the Royan Institute, investigates its efficacy in improving semen parameters—including sperm concentration, motility, and morphology—and modulating reproductive hormones like testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in men with idiopathic oligospermia. While its exact molecular mechanism remains under investigation, it is hypothesized to exert antioxidant effects and influence the hypothalamic-pituitary-gonadal (HPG) axis, thereby protecting sperm DNA from oxidative damage and enhancing hormonal drivers of spermatogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on red bahman.